Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge
Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients? - Raffaella Palumbo, Federico Sottotetti, Antonio Bernardo, 2016
![Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force☆ - ESMO Open Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force☆ - ESMO Open](https://www.esmoopen.com/cms/asset/bfff9f06-193a-4b45-a3e1-41aca878b641/gr1.jpg)
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force☆ - ESMO Open
![Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience - Falanga - 2022 - Thoracic Cancer - Wiley Online Library Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience - Falanga - 2022 - Thoracic Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e6a441f6-b952-4dbc-bb35-16c9ffa14e99/tca14627-fig-0001-m.jpg)
Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience - Falanga - 2022 - Thoracic Cancer - Wiley Online Library
![Federico Sottotetti's research works | Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Fondazione Maugeri) and other places Federico Sottotetti's research works | Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Fondazione Maugeri) and other places](https://www.researchgate.net/publication/349954295/figure/fig1/AS:1020689633009666@1620362780542/The-figure-shows-the-CONSORT-flow-chart_Q320.jpg)
Federico Sottotetti's research works | Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Fondazione Maugeri) and other places
![Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study - Vincenzo Adamo, Giuseppina Rosaria Rita Ricciardi, Dario Giuffrida, Giuseppa Scandurra, Antonio Russo, Livio Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study - Vincenzo Adamo, Giuseppina Rosaria Rita Ricciardi, Dario Giuffrida, Giuseppa Scandurra, Antonio Russo, Livio](https://journals.sagepub.com/cms/10.1177/1758835919895755/asset/images/large/10.1177_1758835919895755-fig1.jpeg)